78 related articles for article (PubMed ID: 9280403)
1. Characterization of carbamazepine metabolism in a mouse model of carbamazepine teratogenicity.
Amore BM; Kalhorn TF; Skiles GL; Hunter AP; Bennett GD; Finnell RH; Nelson SD; Slattery JT
Drug Metab Dispos; 1997 Aug; 25(8):953-62. PubMed ID: 9280403
[TBL] [Abstract][Full Text] [Related]
2. Teratogenicity of carbamazepine-10, 11-epoxide and oxcarbazepine in the SWV mouse.
Bennett GD; Amore BM; Finnell RH; Wlodarczyk B; Kalhorn TF; Skiles GL; Nelson SD; Slattery JT
J Pharmacol Exp Ther; 1996 Dec; 279(3):1237-42. PubMed ID: 8968346
[TBL] [Abstract][Full Text] [Related]
3. Protein-reactive metabolites of carbamazepine in mouse liver microsomes.
Lillibridge JH; Amore BM; Slattery JT; Kalhorn TF; Nelson SD; Finnell RH; Bennett GD
Drug Metab Dispos; 1996 May; 24(5):509-14. PubMed ID: 8723729
[TBL] [Abstract][Full Text] [Related]
4. Effect of treatment with phenobarbital and stiripentol on carbamazepine-induced teratogenicity and reactive metabolite formation.
Finnell RH; Bennett GD; Slattery JT; Amore BM; Bajpai M; Levy RH
Teratology; 1995 Dec; 52(6):324-32. PubMed ID: 8711619
[TBL] [Abstract][Full Text] [Related]
5. Bioactivation of carbamazepine in the rat in vivo. Evidence for the formation of reactive arene oxide(s).
Madden S; Maggs JL; Park BK
Drug Metab Dispos; 1996 Apr; 24(4):469-79. PubMed ID: 8801063
[TBL] [Abstract][Full Text] [Related]
6. Carbamazepine and carbamazepine-10,11- epoxide during pregnancy and postnatal period in epileptic mother and their nursed infants: pharmacokinetics and clinical effects.
Kuhnz W; Jäger-Roman E; Rating D; Deichl A; Kunze J; Helge H; Nau H
Pediatr Pharmacol (New York); 1983; 3(3-4):199-208. PubMed ID: 6677873
[TBL] [Abstract][Full Text] [Related]
7. In vitro embryotoxicity of carbamazepine and carbamazepine-10, 11-epoxide.
Hansen DK; Dial SL; Terry KK; Grafton TF
Teratology; 1996 Jul; 54(1):45-51. PubMed ID: 8916369
[TBL] [Abstract][Full Text] [Related]
8. Human in vitro glutathionyl and protein adducts of carbamazepine-10,11-epoxide, a stable and pharmacologically active metabolite of carbamazepine.
Bu HZ; Kang P; Deese AJ; Zhao P; Pool WF
Drug Metab Dispos; 2005 Dec; 33(12):1920-4. PubMed ID: 16204461
[TBL] [Abstract][Full Text] [Related]
9. Identification of primary and sequential bioactivation pathways of carbamazepine in human liver microsomes using liquid chromatography/tandem mass spectrometry.
Bu HZ; Zhao P; Dalvie DK; Pool WF
Rapid Commun Mass Spectrom; 2007; 21(20):3317-22. PubMed ID: 17879390
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and disposition of 1-bromopropane in rats and mice following inhalation or intravenous administration.
Garner CE; Sumner SC; Davis JG; Burgess JP; Yueh Y; Demeter J; Zhan Q; Valentine J; Jeffcoat AR; Burka LT; Mathews JM
Toxicol Appl Pharmacol; 2006 Aug; 215(1):23-36. PubMed ID: 16513153
[TBL] [Abstract][Full Text] [Related]
11. Individual and combined antiepileptic and neurotoxic activity of carbamazepine and carbamazepine-10,11-epoxide in mice.
Bourgeois BF; Wad N
J Pharmacol Exp Ther; 1984 Nov; 231(2):411-5. PubMed ID: 6491988
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography/mass spectrometry.
Maggs JL; Pirmohamed M; Kitteringham NR; Park BK
Drug Metab Dispos; 1997 Mar; 25(3):275-80. PubMed ID: 9172943
[TBL] [Abstract][Full Text] [Related]
13. Role of cytochrome P-450 2E1 in methacrylonitrile metabolism and disposition.
Ghanayem BI; Sanders JM; Chanas B; Burka LT; Gonzalez FJ
J Pharmacol Exp Ther; 1999 May; 289(2):1054-9. PubMed ID: 10215687
[TBL] [Abstract][Full Text] [Related]
14. Identification of phenobarbital N-glucuronides as urinary metabolites of phenobarbital in mice.
Neighbors SM; Soine WH
Drug Metab Dispos; 1995 May; 23(5):548-52. PubMed ID: 7587929
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
16. N-glucuronidation of carbamazepine in human tissues is mediated by UGT2B7.
Staines AG; Coughtrie MW; Burchell B
J Pharmacol Exp Ther; 2004 Dec; 311(3):1131-7. PubMed ID: 15292462
[TBL] [Abstract][Full Text] [Related]
17. A PLS-based extractive spectrophotometric method for simultaneous determination of carbamazepine and carbamazepine-10,11-epoxide in plasma and comparison with HPLC.
Hemmateenejad B; Rezaei Z; Khabnadideh S; Saffari M
Spectrochim Acta A Mol Biomol Spectrosc; 2007 Nov; 68(3):718-24. PubMed ID: 17307386
[TBL] [Abstract][Full Text] [Related]
18. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of carbamazepine.
Lertratanangkoon K; Horning MG
Drug Metab Dispos; 1982; 10(1):1-10. PubMed ID: 6124375
[TBL] [Abstract][Full Text] [Related]
20. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
